Analyst Price Target is C$5.65
▼ -0.88% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for NorthWest Health Prop Real Est Inv Trust in the last 3 months. The average price target is C$5.65, with a high forecast of C$6.50 and a low forecast of C$5.25. The average price target represents a -0.88% upside from the last price of C$5.70.
Current Consensus is
Hold
The current consensus among 6 investment analysts is to hold stock in NorthWest Health Prop Real Est Inv Trust. This rating has held steady since November 2022, when it changed from a Moderate Buy consensus rating.
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages 230 professionals across nine offices in five countries to serve as a long-term real estate partner to leading healthcare operators.
Read More